Provided by Tiger Trade Technology Pte. Ltd.

Nasdaq

81.48
-2.3000-2.75%
Post-market: 81.15-0.3300-0.41%19:59 EDT
Volume:2.94M
Turnover:240.78M
Market Cap:46.52B
PE:26.37
High:83.10
Open:82.86
Low:81.00
Close:83.78
52wk High:101.79
52wk Low:64.84
Shares:571.00M
Float Shares:511.57M
Volume Ratio:0.96
T/O Rate:0.57%
Dividend:1.05
Dividend Rate:1.29%
EPS(TTM):3.09
EPS(LYR):3.09
ROE:15.25%
ROA:5.06%
PB:3.81
PE(LYR):26.37

Loading ...

D-BOX launches NCIB to repurchase up to 20,960,088 shares

Reuters
·
Mar 24

Inventiva updates financial calendar for 2025 full-year results release and conference call

Reuters
·
Mar 24

Weatherford schedules first-quarter 2026 results conference call

Reuters
·
Mar 24

Timbercreek Financial declares CAD 0.0575 monthly dividend per share

Reuters
·
Mar 24

Cboe Global Markets Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 24

Battalion Oil Q4 2025 operating revenues fall 35% to USD 32 million as net loss available to common stockholders narrows 59% to USD 13 million

Reuters
·
Mar 24

Rogers Communications Inc. updates financial calendar with Q1 2026 results call and AGM

Reuters
·
Mar 24

Atlantic Petroleum reschedules annual report release and AGM date

Reuters
·
Mar 24

Vor Bio reports inducement grants of 215,700 stock options and 46,235 RSUs under Nasdaq Rule 5635(c)(4)

Reuters
·
Mar 24

Host Hotels & Resorts schedules first-quarter 2026 earnings call and webcast

Reuters
·
Mar 24

Garden Stage regains Nasdaq compliance with $1 minimum bid price rule

Reuters
·
Mar 24

Atlantic Petroleum expects debt restructuring agreement signatures within weeks

Reuters
·
Mar 24

Altai Resources Inc. held shareholder meeting on asset sales and TSXV delisting

Reuters
·
Mar 24

Context Therapeutics targets June 2026 interim Phase 1a data for CTIM-76 bispecific antibody trial

Reuters
·
Mar 24

Slide Insurance authorizes USD 125 million stock buyback after completing USD 120 million program

Reuters
·
Mar 24

Beyond Oil flags potential delay in 2025 annual filings past March 31, 2026 deadline

Reuters
·
Mar 24

Surrozen FY 2025 net loss widens to USD 242 million as R&D expense rises 39% to USD 29 million

Reuters
·
Mar 24

Aardvark Therapeutics Q4 net loss rises 100% to USD 18 million on R&D expense up 77% to USD 14 million

Reuters
·
Mar 24

Parsons wins GDOT contract to upgrade statewide ATMS with iNET platform

Reuters
·
Mar 24

Sutro Biopharma FY 2025 revenue rises 65.2% to USD 102 million, net loss narrows to USD 191 million

Reuters
·
Mar 24